ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 73 filers reported holding ACELRX PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.57 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $0 | – | 1,000 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | – | 1,000 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | -100.0% | 1,000 | 0.0% | 0.00% | -100.0% |
| Q4 2021 | $1,000 | 0.0% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $1,000 | 0.0% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $1,000 | -50.0% | 1,000 | 0.0% | 0.00% | -66.7% |
| Q1 2021 | $2,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Values First Advisors, Inc. | 250,110 | $528,000 | 0.51% |
| XTX MARKETS LLC | 12,925 | $27,000 | 0.19% |
| Cornerstone Capital, Inc. | 491,560 | $1,037,000 | 0.15% |
| Aristides Capital LLC | 64,482 | $136,000 | 0.10% |
| LINCOLN CAPITAL CORP | 57,000 | $120,000 | 0.09% |
| HighVista Strategies LLC | 41,400 | $87,000 | 0.07% |
| Ahrens Investment Partners LLC | 61,500 | $130,000 | 0.05% |
| J Arnold Wealth Management Co | 18,000 | $38,000 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 114,437 | $241,000 | 0.03% |
| Avidian Wealth Solutions, LLC | 63,000 | $133,000 | 0.02% |